Thiologics developing a groundbreaking site-specific conjugation platform that will enable the assembly of the next generation of Biologics.
Business Model:
Revenue: $0
Employees: 1-10
Address: 97 Tottenham Court Road
City: Greater London
State: england
Zip: W1T 4TP
Country: GB
ThioLogics has developed a groundbreaking site-specific conjugation platform that will enable the assembly of the next generation of Biologics. ThioLogics groundbreaking conjugation platform allows the selective, stable, functional modification of disulfide bonds or free cysteine in proteins and peptides. Technology that will allow versatile modification of proteins to yield well-defined, homogeneous products is highly desirable. In particular, it has been demonstrated that homogeneous antibody-drug conjugates (ADCs) have a greatly improved therapeutic index over analogous heterogeneous formulations. Introducing greater homogeneity into protein conjugates will also greatly simplify process and development issues, thus reducing costs.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|